02.07.19 | news

STAT – New York biotech debuts, targeting dormant metastatic cancer cells

A biotech based on the frightening fact that some cancer cells spread throughout the body even before a tumor is detectable emerged from stealth mode on Thursday, announcing it had raised roughly $60 million from, among others, early-stage venture capital companies and one of biotech’s 800-pound gorillas.

Read full story by Sharon Begley here.